Trial Profile

A planned study will compare the transdermal absorption of oxymorphone from application of the patch to different parts of the body

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 14 Aug 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Oxymorphone (Primary)
Indications Pain
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

14 Aug 2014 New trial record
11 Aug 2014 According to a Phosphagenics media release issued in August 2014, this study will be initiated shortly. That study will inform the selection of appropriate sites for application of patches during Phase 2.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com